Treatment Planning & Protocols Flashcards
7 cards from real CLT practice questions. Tap to flip, then mark Knew It or Still Learning — missed cards come back until you master them.
Read the first 7 Treatment Planning & Protocols flashcards as text
When calculating dosimetry for low-level laser therapy (LLLT), which parameter directly determines the energy density (fluence) delivered to tissue?
Answer: Power density multiplied by treatment time
Fluence (J/cm²) is calculated by multiplying power density (W/cm²) by treatment time (seconds).
A patient presents with acute tendinitis. According to standard LLLT protocols, which energy dose range is most appropriate for an acute inflammatory condition?
Answer: 1–4 J/cm²
Acute conditions typically respond to lower doses of 1–4 J/cm², while chronic conditions may require 4–12 J/cm².
Which wavelength range is most effective for targeting deep musculoskeletal tissues (3–5 cm depth)?
Answer: 780–1000 nm (near-infrared)
Near-infrared wavelengths (780–1000 nm) penetrate deepest into tissue, reaching musculoskeletal structures at 3–5 cm.
When treating a large surface area wound with laser therapy, the therapist should apply which scanning technique to ensure uniform coverage?
Answer: Grid or scanning method moving across the treatment zone
A grid or scanning technique ensures that the entire wound surface receives a uniform dose of therapeutic energy.
A patient taking photosensitizing medications (e.g., tetracycline) requires laser therapy. What is the most appropriate protocol adjustment?
Answer: Reduce dose, avoid UV-visible wavelengths, and monitor skin response
Photosensitizing drugs increase the risk of adverse skin reactions; dose reduction and wavelength selection away from UV-visible range are essential.
Which tissue chromophore primarily absorbs near-infrared laser energy and initiates the mitochondrial photobiomodulation cascade?
Answer: Cytochrome c oxidase
Cytochrome c oxidase in the mitochondrial respiratory chain is the primary photoacceptor for near-infrared photobiomodulation.
For a treatment plan targeting peripheral neuropathy, what treatment frequency is most commonly recommended in clinical protocols?
Answer: 3–5 times per week for the initial phase
Peripheral neuropathy protocols typically call for 3–5 sessions per week during the initial treatment phase to optimize neuronal response.